Using those cut-off values in the Kaplan–Meier analysis, COVID-19 patients with highly elevated VCAM-1 levels had a significantly higher risk of 30-day mortality compared to those with lower values (with a death ratio of 68% vs. 37%, respectively, Log rank p = 0.0031) (Figure 2D). This evidence concerns the gene VCAM1 and COVID-19.